Cefoselis
Jump to navigation
Jump to search
![]() | |
Names | |
---|---|
IUPAC name
(6R,7R)-3-[[3-amino-2-(2-hydroxyethyl)pyrazol-1-ium-1-yl]methyl]-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
| |
Other names
Wincef
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
PubChem CID
|
|
UNII | |
| |
| |
Properties | |
C19H22N8O6S2 | |
Molar mass | 522.55 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Cefoselis is a fourth generation cephalosporin. It is used extensively in Japan and China in the clinical treatment of various gram positive and gram negative infections. A 2014 study illustrated that Cefoselis is effective at treating respiratory and urinary tract infections.[1]
References
- ^ "Multicenter, double-blind, randomized clinical trial of parenterally administered Cefoselis versus Cefepime for the treatment of acute bacterial infections". European Review. 2014-07-10. Retrieved 2022-08-03.
Categories:
- Articles without KEGG source
- Articles with changed EBI identifier
- Pages using collapsible list with both background and text-align in titlestyle
- Articles containing unverified chemical infoboxes
- Chembox image size set
- Articles with short description
- Short description with empty Wikidata description
- Pyrazoles
- Thiazoles
- Cephalosporin antibiotics
- All stub articles
- Antibiotic stubs